FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine

PHASE2CompletedINTERVENTIONAL
Enrollment

127

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2017

Study Completion Date

March 31, 2021

Conditions
Metastatic Pancreatic Cancer
Interventions
DRUG

FOLFIRI.3

For each cycle : 1 week out of 2 - injection at Day1, J15 Irinotécan 90 mg/m² at day1 in perfusion over 60 min in Y of folinic acid Folinic Acid 400 mg/m² (or 200 mg/m² Elvorine) at Day 1 in perfusion over 2 hours 5FU continu 2000 mg/m² during 46 hours Irinotécan at 90 mg/m² in perfusion over 60 mn at Day 3 (when 5FU perfusion is over)

DRUG

nab-paclitaxel+ gemcitabine

For each cycle : 3 weeks out of 4 - injection at Day 1, 8 and 15 Nab-paclitaxel : 125 mg/m² of nab-paclitaxel in perfusion over 30 mn. Gemcitabine 1000 mg/m² in perfusion over 30 mn immediately after Nab paclitaxel administration is over.

Trial Locations (37)

13331

Hopital Europeen Marseille, Marseille

75020

HEGP, Paris

75651

Hôpital La Pitié Salpêtrière, Paris

94805

Gustave Roussy, Villejuif

Unknown

Clinique Privée Claude Bernard, Albi

CH, Blois

Clinique Tivoli Ducos, Bordeaux

Hôpital Duchenne, Boulogne-sur-Mer

CH Pierre Oudot, Bourgoin

Centre François Baclesse, Caen

CHR côte de Nacre, Caen

Centre Hospitalier Sud Francilien, Corbeil-Essonnes

Centre GF Leclerc, Dijon

CH de la Dracénie, Draguignan

Ch Jacques Monod, Flers

CH, Fréjus

CHU, Le Kremlin-Bicêtre

CH, Le Mans

CHU, Limoges

Clinique Chenieux, Limoges

CH, Longjumeau

CH Pierre Benite, Lyon

H Layné, Mont-de-Marsan

Hôpital Cochin, Paris

CH St Jean, Perpignan

Hôpital Haut Lévèque, Pessac

Centre Cario - Hpca Saint Brieuc, Plérin

Hôpitaux Drome Nord, Romans-sur-Isère

CHU, Rouen

CHP, Saint-Grégoire

Clinique Privée, Strasbourg

Hopitaux Du Leman, Thonon-les-Bains

Clinique Pasteur Groupe ONCORAD GARONNE, Toulouse

Clinique Privée Pasteur, Toulouse

Clinique Privée Saint Jean, Toulouse

Clinique St Jean Languedoc, Toulouse

Hôpital Paul Brousse, Villejuif

All Listed Sponsors
collaborator

UNICANCER

OTHER

collaborator

GERCOR - Multidisciplinary Oncology Cooperative Group

OTHER

lead

Federation Francophone de Cancerologie Digestive

OTHER

NCT02827201 - FIrst Line Treatment of Metastatic Pancreatic Cancer: Sequential Nab-paclitaxel + Gemcitabine/FOLFIRI.3 VS Nab-paclitaxel + Gemcitabine | Biotech Hunter | Biotech Hunter